Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obesity
Biotech
UPDATE: Lilly-backed metabolic disease biotech files IPO
After raising $170 million back in February, metabolic disease-focused BioAge Labs has filed to debut on the public markets.
Gabrielle Masson
Sep 4, 2024 10:23am
Arrowhead dips toes into obesity pond with 2 preclinical assets
Aug 14, 2024 3:50pm
'All hands on deck' at Lilly as peers target obesity market
Aug 8, 2024 1:40pm
‘Not prudent’ for Novartis to join GLP-1 obesity race, says CEO
Jul 18, 2024 10:03am
Pfizer, Flagship name first target for $7B collab: obesity
Jun 12, 2024 8:25am
NodThera's NLRP3 inhibitor shows obesity promise in early trial
Jun 12, 2024 7:00am